Stock information Stock information
IR

G9PHARMA always tries to be the best technology company.

Financial information

The financial information of G9PHARMA.

주요재무정보
Info Yearly
2016/12
(IFRS)
2017/12
(IFRS)
2018/12
(IFRS)
2019/12
(IFRS)
2020/12
(IFRS)
2021/12(E)
(IFRS)
2022/12(E)
(IFRS)
2023/12(E)
(IFRS)
Revenue 930 820 779 677 416
Operationg income -89 -111 44 32 -319
Operationg income(Presentation standards) -89 -111 44 32 -319
Income before tax -155 -226 63 -85 -455
Earning -156 -227 63 -87 -455
Earning(controlling) -156 -227 63 -87 -451
Earning(Non-controlling) -5
Total assets 1,142 770 751 973 780
Total liabilities 902 513 429 468 573
Total shareholders' equity 240 258 322 504 207
Total shareholders' equity(controlling) 240 258 322 504 207
Total shareholders' equity(Non-controlling)
Share Capital 69 150 150 214 345
Cashflow from Operating Activities 101 16 192 108 -201
Cashflow from Investing Activities -53 60 -154 -259 27
Cashflow from Financing Activities -51 -36 -2 89 219
CAPEX 115 109 131 301 36
FCF -14 -93 61 -193 -236
Interest-bearing liabilities 615 317 230 289 338
Operating Profit -9.61 -13.48 5.60 4.79 -76.72
ROS -16.75 -27.62 8.06 -12.81 -109.58
ROE(%) -63.19 -91.06 21.65 -21.00 -126.69
ROA(%) -12.75 -23.69 8.25 -10.07 -51.95
debt ratio 375.86 199.10 133.13 92.88 276.92
Reserve ratio 248.17 82.51 124.83 137.64 -40.37
EPS(KRW) -1,057 -1,048 180 -200 -837
PER N/A N/A 6.31 N/A N/A
BPS(KRW) 1,411 740 925 1,020 300
PBR 2.17 1.79 1.23 1.60 3.35
Cash DPS(KRW) 0 0 0 0 0
Cash Dividend yield 0.00 0.00 0.00 0.00 0.00
dividend payout ratio(%) 0.00 0.00 0.00 0.00 0.00
outstanding shares issed(common share) 17,009,681 34,804,209 34,804,209 49,435,428 68,975,373